10 results
Ketosis Disorders - Comparison Table
 • Starvation Ketosis
 • Alcoholic Ketoacidosis (AKA)
 • Diabetic Ketoacidosis (DKA)
Disorders - Comparison Table ... (AKA) • Diabetic ... Ketoacidosis (DKA ... differential #diagnosis #management ... #endocrinology
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
#SideEffects #Table ... DecisionAid #Orals #DM2 #Diabetes ... #Endocrinology ... #Pharmacology #Management
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #medications #table ... #comparison #management ... #endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... pharmacotherapy #table ... #comparison #management ... #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Calculate total daily dose ... Adjust insulin dose ... pharmacology #comparison #table ... #endocrinology
Drugs for Depression and Anxiety Disorders

Selective Serotonin Reuptake Inhibitors
 • Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline,
to prevent NE, DA ... Insomnia (low-dose ... #Medications #Table ... #Pharmacology #Management
Optimal glycemic control is fundamental to the management of diabetes.

A1C% measurement approximately every 3 months determines
fundamental to the management ... of diabetes. ... guidelines #management ... #endocrinology ... #treatment #table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
functional status - Able ... metabolic equivalent able ... Stable patients ... Diabetes regimen ... medical and surgical management
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
mg maintenance dose ... the maintenance dose ... drug to remain stable ... #semaglutide #Diabetes ... #Pharmacology #Endocrinology
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Diagnosis and Management ... ↓insulin (DM, DKA ... clear cause) Management ... Elimination (see Table ... Transient, repeat dose